Ablation with Low-Dose(1.1GBq) and High-Dose(3.7GBq) Radioiodine in Postoperative Low and Intermediate Risk Differentiated Thyroid Cancer

被引:0
|
作者
Qu, Yuan [1 ]
Huang, Rui [1 ]
Li, Lin [1 ]
机构
[1] West China Hosp, Chengdu, Sichuan, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1775
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Postoperative thyroid remnants for differentiated thyroid cancer may not affect the outcome of high-dose radioiodine therapy
    Pan, Liqin
    Chen, Yanying
    Li, Sixiao
    Ouyang, Wei
    Feng, Huijuan
    Wu, Juqing
    Chen, Pan
    Deng, Yuying
    Wang, Jing
    Luo, Jiaxin
    Xian, Jialan
    ORAL ONCOLOGY, 2020, 104
  • [42] Comparison of the Prescribed Dose of Radioiodine Ablation (Low Dose versus High Dose) in patients with Intermediate to High Risk Thyroid Cancer: An Inverse Probability of Treatment Weighting Analysis
    Iizuka, Y.
    Katagiri, T.
    Ogura, K.
    Mizowaki, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S784 - S784
  • [43] Quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer
    Abdulrezzak, Ummuhan
    Tutus, Ahmet
    Isik, Ilknur
    Kurt, Yurdagul
    Kula, Mustafa
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (03): : 314 - 322
  • [44] The quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer
    Abdulrezzak, U.
    Tutus, A.
    Kula, M.
    Kurt, Y.
    Kocaagaoglu, E.
    Sarikaya, Y.
    Isik, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S127 - S127
  • [45] Our first experience with low dose radioiodine ablation Therapy in low risk patients with differentiated thyroid carcinoma
    Rajkovaca, Z.
    Mijatovic, J.
    Skrobic, M.
    Mikac, G.
    Vuleta, G.
    Matavulj, A.
    Kovacevic, P.
    Ponorac, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S356 - S356
  • [46] Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis
    I. Vardarli
    F. Weidemann
    M. Aboukoura
    K. Herrmann
    I. Binse
    R. Görges
    BMC Cancer, 20
  • [47] Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis
    Vardarli, I.
    Weidemann, F.
    Aboukoura, M.
    Herrmann, K.
    Binse, I.
    Goerges, R.
    BMC CANCER, 2020, 20 (01)
  • [48] Recombinant Human Thyroid Stimulating Hormone in Thyroid Remnant Ablation With 1.1 GBq 131Iodine in Low-Risk Patients
    Rosario, Pedro Weslley
    Malard Xavier, Arthur Cezar
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 101 - 104
  • [49] EVALUATION OF LOW-DOSE RADIOIODINE ABLATION THERAPY IN POSTSURGICAL THYROID-CANCER PATIENTS
    RAMANNA, L
    WAXMAN, AD
    BRACHMAN, MB
    TANASESCU, DE
    SENSEL, N
    BRAUNSTEIN, GD
    CLINICAL NUCLEAR MEDICINE, 1985, 10 (11) : 791 - 795
  • [50] Efficacy of low radioiodine activity versus intermediate-high activity in the ablation of low-risk differentiated thyroid cancer
    Albano, Domenico
    Bonacina, Mattia
    Durmo, Rexhep
    Bertagna, Francesco
    Giubbini, Raffaele
    ENDOCRINE, 2020, 68 (01) : 124 - 131